Initial studies using ELISAs developed for determining TDP-43 [379] demonstrated elevated levels of total TDP-43 and pTDP-43 in CSF of patients with TDP-43 proteinopathies, including ALS, FTD and AD [380–382]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.